EINSPRITZVORRICHTUNG

Patent europeic · EP3380171 · En vigur

Inscripziun en il register

Numer da publicaziun
EP3380171
Numer da la dumonda
EP16804709
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
En vigur
Scrittira da patent
Concedì
Annunzià
21-11-2016
Publitgà
03-10-2018
Concedì
08-04-2026
La protecziun finescha il pli tard
20-11-2036
Proxima taxa annuala scadenta
30-11-2026
Classas IPC
A61M 5/32 (2006.01)
Prioritad
EP 15196675 27.11.2015
Dumonda PCT
PCT/EP2016/078247 21.11.2016
Publicaziun PCT
WO2017/089259 01.06.2017
Lingua da l’annunzia
englais
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 08-04-2026

    Concedì

    Specification status
    Non-published patent application → Granted patent
    Status of protective title
    Initiated → Active

    Published in Swissreg on 08.04.2026

Partidas

Possessur

Sanofi-Aventis Deutschland GmbH

Brüningstraße 50, 65929 Frankfurt am Main, DE

Inventur

WENDLAND, Stefan

65926 Frankfurt am Main, DE

HARMS, Michael

65926 Frankfurt am Main, DE

DASBACH, Uwe

65926 Frankfurt am Main, DE

EICKRIEDE, Jan Torben

65926 Frankfurt am Main, DE

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.